• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Influenza Therapeutics Market Size, Status and Forecast 2020-2026

report cover
  • 22 June 2020
  • Pharmaceuticals
  • 93 Pages
  • Report Code: 24LS-8644
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Influenza Therapeutics -MARKET ADVISORY SERVICES

This report focuses on the global Influenza Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Influenza Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott Laboratories
Astrazeneca PLC
Biocryst Pharmaceuticals, Inc.
Chiron Corporation
CSL Limited
Daiichi Sankyo Co., Ltd.
Glaxosmithkline PLC
Mitsubishi Tanabe Pharma Corporation
Nanotherapeutics Inc.
Protein Sciences Corporation
Roche Holding AG
Sanofi SA
Shionogi & Co., Ltd.
Sinovac Biotech Ltd.

Market segment by Type, the product can be split into
Vaccines
Drugs
Market segment by Application, split into
Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Influenza Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Influenza Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Influenza Therapeutics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Influenza Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Influenza Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Vaccines
1.4.3 Drugs
1.5 Market by Application
1.5.1 Global Influenza Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Influenza Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the Influenza Therapeutics Industry
1.6.1.1 Influenza Therapeutics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Influenza Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Influenza Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Influenza Therapeutics Market Perspective (2015-2026)
2.2 Influenza Therapeutics Growth Trends by Regions
2.2.1 Influenza Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Influenza Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Influenza Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Influenza Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Influenza Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Influenza Therapeutics Players by Market Size
3.1.1 Global Top Influenza Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Influenza Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Influenza Therapeutics Market Concentration Ratio
3.2.1 Global Influenza Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Influenza Therapeutics Revenue in 2019
3.3 Influenza Therapeutics Key Players Head office and Area Served
3.4 Key Players Influenza Therapeutics Product Solution and Service
3.5 Date of Enter into Influenza Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Influenza Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Influenza Therapeutics Forecasted Market Size by Type (2021-2026)

5 Influenza Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Influenza Therapeutics Market Size by Application (2015-2020)
5.2 Global Influenza Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Influenza Therapeutics Market Size (2015-2020)
6.2 Influenza Therapeutics Key Players in North America (2019-2020)
6.3 North America Influenza Therapeutics Market Size by Type (2015-2020)
6.4 North America Influenza Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Influenza Therapeutics Market Size (2015-2020)
7.2 Influenza Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Influenza Therapeutics Market Size by Type (2015-2020)
7.4 Europe Influenza Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Influenza Therapeutics Market Size (2015-2020)
8.2 Influenza Therapeutics Key Players in China (2019-2020)
8.3 China Influenza Therapeutics Market Size by Type (2015-2020)
8.4 China Influenza Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Influenza Therapeutics Market Size (2015-2020)
9.2 Influenza Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Influenza Therapeutics Market Size by Type (2015-2020)
9.4 Japan Influenza Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Influenza Therapeutics Market Size (2015-2020)
10.2 Influenza Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Influenza Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Influenza Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Influenza Therapeutics Market Size (2015-2020)
11.2 Influenza Therapeutics Key Players in India (2019-2020)
11.3 India Influenza Therapeutics Market Size by Type (2015-2020)
11.4 India Influenza Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Influenza Therapeutics Market Size (2015-2020)
12.2 Influenza Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Influenza Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Influenza Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories Influenza Therapeutics Introduction
13.1.4 Abbott Laboratories Revenue in Influenza Therapeutics Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Astrazeneca PLC
13.2.1 Astrazeneca PLC Company Details
13.2.2 Astrazeneca PLC Business Overview and Its Total Revenue
13.2.3 Astrazeneca PLC Influenza Therapeutics Introduction
13.2.4 Astrazeneca PLC Revenue in Influenza Therapeutics Business (2015-2020)
13.2.5 Astrazeneca PLC Recent Development
13.3 Biocryst Pharmaceuticals, Inc.
13.3.1 Biocryst Pharmaceuticals, Inc. Company Details
13.3.2 Biocryst Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Introduction
13.3.4 Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2015-2020)
13.3.5 Biocryst Pharmaceuticals, Inc. Recent Development
13.4 Chiron Corporation
13.4.1 Chiron Corporation Company Details
13.4.2 Chiron Corporation Business Overview and Its Total Revenue
13.4.3 Chiron Corporation Influenza Therapeutics Introduction
13.4.4 Chiron Corporation Revenue in Influenza Therapeutics Business (2015-2020)
13.4.5 Chiron Corporation Recent Development
13.5 CSL Limited
13.5.1 CSL Limited Company Details
13.5.2 CSL Limited Business Overview and Its Total Revenue
13.5.3 CSL Limited Influenza Therapeutics Introduction
13.5.4 CSL Limited Revenue in Influenza Therapeutics Business (2015-2020)
13.5.5 CSL Limited Recent Development
13.6 Daiichi Sankyo Co., Ltd.
13.6.1 Daiichi Sankyo Co., Ltd. Company Details
13.6.2 Daiichi Sankyo Co., Ltd. Business Overview and Its Total Revenue
13.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Introduction
13.6.4 Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
13.6.5 Daiichi Sankyo Co., Ltd. Recent Development
13.7 Glaxosmithkline PLC
13.7.1 Glaxosmithkline PLC Company Details
13.7.2 Glaxosmithkline PLC Business Overview and Its Total Revenue
13.7.3 Glaxosmithkline PLC Influenza Therapeutics Introduction
13.7.4 Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2015-2020)
13.7.5 Glaxosmithkline PLC Recent Development
13.8 Mitsubishi Tanabe Pharma Corporation
13.8.1 Mitsubishi Tanabe Pharma Corporation Company Details
13.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview and Its Total Revenue
13.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Introduction
13.8.4 Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2015-2020)
13.8.5 Mitsubishi Tanabe Pharma Corporation Recent Development
13.9 Nanotherapeutics Inc.
13.9.1 Nanotherapeutics Inc. Company Details
13.9.2 Nanotherapeutics Inc. Business Overview and Its Total Revenue
13.9.3 Nanotherapeutics Inc. Influenza Therapeutics Introduction
13.9.4 Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2015-2020)
13.9.5 Nanotherapeutics Inc. Recent Development
13.10 Protein Sciences Corporation
13.10.1 Protein Sciences Corporation Company Details
13.10.2 Protein Sciences Corporation Business Overview and Its Total Revenue
13.10.3 Protein Sciences Corporation Influenza Therapeutics Introduction
13.10.4 Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2015-2020)
13.10.5 Protein Sciences Corporation Recent Development
13.11 Roche Holding AG
10.11.1 Roche Holding AG Company Details
10.11.2 Roche Holding AG Business Overview and Its Total Revenue
10.11.3 Roche Holding AG Influenza Therapeutics Introduction
10.11.4 Roche Holding AG Revenue in Influenza Therapeutics Business (2015-2020)
10.11.5 Roche Holding AG Recent Development
13.12 Sanofi SA
10.12.1 Sanofi SA Company Details
10.12.2 Sanofi SA Business Overview and Its Total Revenue
10.12.3 Sanofi SA Influenza Therapeutics Introduction
10.12.4 Sanofi SA Revenue in Influenza Therapeutics Business (2015-2020)
10.12.5 Sanofi SA Recent Development
13.13 Shionogi & Co., Ltd.
10.13.1 Shionogi & Co., Ltd. Company Details
10.13.2 Shionogi & Co., Ltd. Business Overview and Its Total Revenue
10.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Introduction
10.13.4 Shionogi & Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
10.13.5 Shionogi & Co., Ltd. Recent Development
13.14 Sinovac Biotech Ltd.
10.14.1 Sinovac Biotech Ltd. Company Details
10.14.2 Sinovac Biotech Ltd. Business Overview and Its Total Revenue
10.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Introduction
10.14.4 Sinovac Biotech Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
10.14.5 Sinovac Biotech Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Influenza Therapeutics Key Market Segments

Table 2. Key Players Covered: Ranking by Influenza Therapeutics Revenue

Table 3. Ranking of Global Top Influenza Therapeutics Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Influenza Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Vaccines

Table 6. Key Players of Drugs

Table 7. COVID-19 Impact Global Market: (Four Influenza Therapeutics Market Size Forecast Scenarios)

Table 8. Opportunities and Trends for Influenza Therapeutics Players in the COVID-19 Landscape

Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 10. Key Regions/Countries Measures against Covid-19 Impact

Table 11. Proposal for Influenza Therapeutics Players to Combat Covid-19 Impact

Table 12. Global Influenza Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 13. Global Influenza Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026

Table 14. Global Influenza Therapeutics Market Size by Regions (2015-2020) (US$ Million)

Table 15. Global Influenza Therapeutics Market Share by Regions (2015-2020)

Table 16. Global Influenza Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 17. Global Influenza Therapeutics Market Share by Regions (2021-2026)

Table 18. Market Top Trends

Table 19. Key Drivers: Impact Analysis

Table 20. Key Challenges

Table 21. Influenza Therapeutics Market Growth Strategy

Table 22. Main Points Interviewed from Key Influenza Therapeutics Players

Table 23. Global Influenza Therapeutics Revenue by Players (2015-2020) (Million US$)

Table 24. Global Influenza Therapeutics Market Share by Players (2015-2020)

Table 25. Global Top Influenza Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Therapeutics as of 2019)

Table 26. Global Influenza Therapeutics by Players Market Concentration Ratio (CR5 and HHI)

Table 27. Key Players Headquarters and Area Served

Table 28. Key Players Influenza Therapeutics Product Solution and Service

Table 29. Date of Enter into Influenza Therapeutics Market

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 32. Global Influenza Therapeutics Market Size Share by Type (2015-2020)

Table 33. Global Influenza Therapeutics Revenue Market Share by Type (2021-2026)

Table 34. Global Influenza Therapeutics Market Size Share by Application (2015-2020)

Table 35. Global Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 36. Global Influenza Therapeutics Market Size Share by Application (2021-2026)

Table 37. North America Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)

Table 38. North America Key Players Influenza Therapeutics Market Share (2019-2020)

Table 39. North America Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 40. North America Influenza Therapeutics Market Share by Type (2015-2020)

Table 41. North America Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 42. North America Influenza Therapeutics Market Share by Application (2015-2020)

Table 43. Europe Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)

Table 44. Europe Key Players Influenza Therapeutics Market Share (2019-2020)

Table 45. Europe Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 46. Europe Influenza Therapeutics Market Share by Type (2015-2020)

Table 47. Europe Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 48. Europe Influenza Therapeutics Market Share by Application (2015-2020)

Table 49. China Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)

Table 50. China Key Players Influenza Therapeutics Market Share (2019-2020)

Table 51. China Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 52. China Influenza Therapeutics Market Share by Type (2015-2020)

Table 53. China Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 54. China Influenza Therapeutics Market Share by Application (2015-2020)

Table 55. Japan Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)

Table 56. Japan Key Players Influenza Therapeutics Market Share (2019-2020)

Table 57. Japan Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 58. Japan Influenza Therapeutics Market Share by Type (2015-2020)

Table 59. Japan Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 60. Japan Influenza Therapeutics Market Share by Application (2015-2020)

Table 61. Southeast Asia Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)

Table 62. Southeast Asia Key Players Influenza Therapeutics Market Share (2019-2020)

Table 63. Southeast Asia Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 64. Southeast Asia Influenza Therapeutics Market Share by Type (2015-2020)

Table 65. Southeast Asia Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 66. Southeast Asia Influenza Therapeutics Market Share by Application (2015-2020)

Table 67. India Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)

Table 68. India Key Players Influenza Therapeutics Market Share (2019-2020)

Table 69. India Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 70. India Influenza Therapeutics Market Share by Type (2015-2020)

Table 71. India Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 72. India Influenza Therapeutics Market Share by Application (2015-2020)

Table 73. Central & South America Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)

Table 74. Central & South America Key Players Influenza Therapeutics Market Share (2019-2020)

Table 75. Central & South America Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 76. Central & South America Influenza Therapeutics Market Share by Type (2015-2020)

Table 77. Central & South America Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 78. Central & South America Influenza Therapeutics Market Share by Application (2015-2020)

Table 79. Abbott Laboratories Company Details

Table 80. Abbott Laboratories Business Overview

Table 81. Abbott Laboratories Product

Table 82. Abbott Laboratories Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 83. Abbott Laboratories Recent Development

Table 84. Astrazeneca PLC Company Details

Table 85. Astrazeneca PLC Business Overview

Table 86. Astrazeneca PLC Product

Table 87. Astrazeneca PLC Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 88. Astrazeneca PLC Recent Development

Table 89. Biocryst Pharmaceuticals, Inc. Company Details

Table 90. Biocryst Pharmaceuticals, Inc. Business Overview

Table 91. Biocryst Pharmaceuticals, Inc. Product

Table 92. Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 93. Biocryst Pharmaceuticals, Inc. Recent Development

Table 94. Chiron Corporation Company Details

Table 95. Chiron Corporation Business Overview

Table 96. Chiron Corporation Product

Table 97. Chiron Corporation Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 98. Chiron Corporation Recent Development

Table 99. CSL Limited Company Details

Table 100. CSL Limited Business Overview

Table 101. CSL Limited Product

Table 102. CSL Limited Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 103. CSL Limited Recent Development

Table 104. Daiichi Sankyo Co., Ltd. Company Details

Table 105. Daiichi Sankyo Co., Ltd. Business Overview

Table 106. Daiichi Sankyo Co., Ltd. Product

Table 107. Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 108. Daiichi Sankyo Co., Ltd. Recent Development

Table 109. Glaxosmithkline PLC Company Details

Table 110. Glaxosmithkline PLC Business Overview

Table 111. Glaxosmithkline PLC Product

Table 112. Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 113. Glaxosmithkline PLC Recent Development

Table 114. Mitsubishi Tanabe Pharma Corporation Business Overview

Table 115. Mitsubishi Tanabe Pharma Corporation Product

Table 116. Mitsubishi Tanabe Pharma Corporation Company Details

Table 117. Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 118. Mitsubishi Tanabe Pharma Corporation Recent Development

Table 119. Nanotherapeutics Inc. Company Details

Table 120. Nanotherapeutics Inc. Business Overview

Table 121. Nanotherapeutics Inc. Product

Table 122. Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 123. Nanotherapeutics Inc. Recent Development

Table 124. Protein Sciences Corporation Company Details

Table 125. Protein Sciences Corporation Business Overview

Table 126. Protein Sciences Corporation Product

Table 127. Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 128. Protein Sciences Corporation Recent Development

Table 129. Roche Holding AG Company Details

Table 130. Roche Holding AG Business Overview

Table 131. Roche Holding AG Product

Table 132. Roche Holding AG Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 133. Roche Holding AG Recent Development

Table 134. Sanofi SA Company Details

Table 135. Sanofi SA Business Overview

Table 136. Sanofi SA Product

Table 137. Sanofi SA Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 138. Sanofi SA Recent Development

Table 139. Shionogi & Co., Ltd. Company Details

Table 140. Shionogi & Co., Ltd. Business Overview

Table 141. Shionogi & Co., Ltd. Product

Table 142. Shionogi & Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 143. Shionogi & Co., Ltd. Recent Development

Table 144. Sinovac Biotech Ltd. Company Details

Table 145. Sinovac Biotech Ltd. Business Overview

Table 146. Sinovac Biotech Ltd. Product

Table 147. Sinovac Biotech Ltd. Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)

Table 148. Sinovac Biotech Ltd. Recent Development

Table 149. Research Programs/Design for This Report

Table 150. Key Data Information from Secondary Sources

Table 151. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Influenza Therapeutics Market Share by Type: 2020 VS 2026

Figure 2. Vaccines Features

Figure 3. Drugs Features

Figure 4. Global Influenza Therapeutics Market Share by Application: 2020 VS 2026

Figure 5. Hospitals Case Studies

Figure 6. Clinic Case Studies

Figure 7. Others Case Studies

Figure 8. Influenza Therapeutics Report Years Considered

Figure 9. Global Influenza Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)

Figure 10. Global Influenza Therapeutics Market Share by Regions: 2020 VS 2026

Figure 11. Global Influenza Therapeutics Market Share by Regions (2021-2026)

Figure 12. Porter's Five Forces Analysis

Figure 13. Global Influenza Therapeutics Market Share by Players in 2019

Figure 14. Global Top Influenza Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Therapeutics as of 2019

Figure 15. The Top 10 and 5 Players Market Share by Influenza Therapeutics Revenue in 2019

Figure 16. North America Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 17. Europe Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 18. China Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. Japan Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Southeast Asia Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. India Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Central & South America Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018

Figure 24. Abbott Laboratories Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 25. Astrazeneca PLC Total Revenue (US$ Million): 2019 Compared with 2018

Figure 26. Astrazeneca PLC Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 27. Biocryst Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 28. Biocryst Pharmaceuticals, Inc. Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 29. Chiron Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 30. Chiron Corporation Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 31. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018

Figure 32. CSL Limited Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 33. Daiichi Sankyo Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 34. Daiichi Sankyo Co., Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 35. Glaxosmithkline PLC Total Revenue (US$ Million): 2019 Compared with 2018

Figure 36. Glaxosmithkline PLC Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 37. Mitsubishi Tanabe Pharma Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 38. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 39. Nanotherapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 40. Nanotherapeutics Inc. Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 41. Protein Sciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 42. Protein Sciences Corporation Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 43. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 44. Roche Holding AG Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 45. Sanofi SA Total Revenue (US$ Million): 2019 Compared with 2018

Figure 46. Sanofi SA Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 47. Shionogi & Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 48. Shionogi & Co., Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 49. Sinovac Biotech Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. Sinovac Biotech Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

Abbott Laboratories

Astrazeneca PLC

Biocryst Pharmaceuticals, Inc.

Chiron Corporation

CSL Limited

Daiichi Sankyo Co., Ltd.

Glaxosmithkline PLC

Mitsubishi Tanabe Pharma Corporation

Nanotherapeutics Inc.

Protein Sciences Corporation

Roche Holding AG

Sanofi SA

Shionogi & Co., Ltd.

Sinovac Biotech Ltd.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3315

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase